Skip to main content

Table 2 Prognostic value of AHNAK for overall survival in triple-negative breast cancer patients by Univariate and Multivariate analyses

From: AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer

Variables Univariate analysis Multivariate analysis
RR 95% IC P value RR 95% IC P value
Age (<50 vs. ≥50 years) 1.137 0.748–1.728 0.548 - - -
Menopause (Yes vs. No) 1.069 0.701–1.630 0.758 - - -
BMI (<25 vs. ≥ 25) 1.057 0.654–1.710 0.820 - - -
Histological grade(G1 + G2 vs. G3) 1.626 1.064–2.485 0.025* 1.272 0.821–1.970 0.282
TNM Staging(I + II vs. III + IV) 3.340 2.199–5.073 <0.001* 2.834 1.827–4.397 <0.001
Ahnak(low vs. high) 2.094 1.366–3.209 0.001* 1.641 1.053–2.558 0.029
  1. *Statistically significant prognostic factor identified by Univariate/Multivariate analysis